Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
49
SBHGF Quote, Financials, Valuation and Earnings
Last price:
$25.50
Seasonality move
:
-2.76%
Day range:
$24.96 - $26.51
52-week range:
$19.00 - $27.90
Dividend yield:
3.92%
P/E ratio:
13.72x
P/S ratio:
0.94x
P/B ratio:
0.88x
Volume:
336
Avg. volume:
909
1-year change:
18.6%
Market cap:
$7.7B
Revenue:
$8.4B
EPS (TTM):
$1.86
Analysts' Opinion
-
Consensus RatingSBI Holdings has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, SBI Holdings has an estimated downside of -- from its current price of $25.50.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $25.50.
Fair Value
-
According to the consensus of 0 analysts, SBI Holdings has -- downside to fair value with a price target of -- per share.
SBHGF vs. S&P 500
-
Over the past 5 trading days, SBI Holdings has underperformed the S&P 500 by -6.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SBI Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SBI Holdings revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter SBI Holdings reported revenues of $2.1B.
Earnings Growth
-
SBI Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter SBI Holdings reported earnings per share of $0.45.
Enterprise value:
13.5B
EV / Invested capital:
--
Price / LTM sales:
0.94x
EV / EBIT:
14.14x
EV / Revenue:
1.63x
PEG ratio (5yr expected):
0.58x
EV / Free cash flow:
1.50x
Price / Operating cash flow:
0.80x
Enterprise value / EBITDA:
10.20x
Gross Profit (TTM):
$4.5B
Return On Assets:
0.33%
Net Income Margin (TTM):
6.79%
Return On Equity:
4.83%
Return On Invested Capital:
1.42%
Operating Margin:
15.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $7.2B | $7.6B | $8.3B | $2.2B | $2.1B | |
| Gross Profit | $4.7B | $4.5B | $4.5B | $1.3B | $1.2B | |
| Operating Income | $1.4B | $968.2M | $956.3M | $333.4M | $334.1M | |
| EBITDA | $1.8B | $1.4B | $1.3B | $439.5M | $425.5M | |
| Diluted EPS | $10.38 | $1.50 | $1.86 | $0.57 | $0.45 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $34.6B | $40B | $107.5B | $98.9B | $124.1B | |
| Total Assets | $59.3B | $68.1B | $148.8B | $162.2B | $200.3B | |
| Current Liabilities | $21.2B | $26B | $88.8B | $87.5B | $105.3B | |
| Total Liabilities | $53.3B | $61B | $136.8B | $150.2B | $187.4B | |
| Total Equity | $6B | $7.1B | $12B | $11.9B | $12.9B | |
| Total Debt | $16.8B | $17.8B | $28.2B | $25.8B | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.8B | $7.1B | $9.3B | -$3.6B | $4.3B | |
| Cash From Investing | $16.4B | -$8B | -$451.2M | $840.6M | -$2.4B | |
| Cash From Financing | $1.5B | $6B | $202.2M | $816.3M | $2.2B | |
| Free Cash Flow | -$3B | $6.8B | $9B | -$3.7B | $4.2B | |
SBHGF
Sector
Market Cap
$7.7B
$698.9M
Price % of 52-Week High
91.4%
88.68%
Dividend Yield
3.92%
2.18%
Shareholder Yield
82.13%
3.87%
1-Year Price Total Return
18.61%
7.42%
Beta (5-Year)
0.970
0.734
Dividend yield:
3.92%
Annualized payout:
$1.06
Payout ratio:
8.58%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$25.84
200-day SMA
Buy
Level
$24.10
Bollinger Bands (100)
Buy
Level
21.42 - 25.02
Chaikin Money Flow
Buy
Level
46.1K
20-day SMA
Sell
Level
$25.55
Relative Strength Index (RSI14)
Buy
Level
53.04
ADX Line
Sell
Level
15.1
Williams %R
Neutral
Level
-61.6967
50-day SMA
Buy
Level
$23.53
MACD (12, 26)
Buy
Level
0.61
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Sell
Level
-15.6K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2426)
Sell
CA Score
(Annual)
Level (-2.5064)
Buy
Beneish M-Score
(Annual)
Level (-2.5985)
Sell
Momentum Score
Level (5)
Sell
Ohlson Score
Level (0.7579)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. Operations are divided into financial services, asset management, and biotechnology-related business. Many of the traditional financial offerings fall under the financial services arm and include housing loans and foreign exchange margin trading in addition to the primary banking and insurance businesses. Under the asset management business, the group invests in Japanese and international venture companies that operate in IT, biotechnology, environment/energy, and finance. Aside from financial services, cosmetics, health foods, and drugs are developed by subsidiaries in the biotech-related business.
Stock Forecast FAQ
In the current month, SBHGF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SBHGF average analyst price target in the past 3 months is --.
-
Where Will SBI Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that SBI Holdings share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SBI Holdings?
Analysts are divided on their view about SBI Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SBI Holdings is a Sell and believe this share price will rise from its current level to --.
-
What Is SBI Holdings's Price Target?
The price target for SBI Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SBHGF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SBI Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SBHGF?
You can purchase shares of SBI Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SBI Holdings shares.
-
What Is The SBI Holdings Share Price Today?
SBI Holdings was last trading at $25.50 per share. This represents the most recent stock quote for SBI Holdings. Yesterday, SBI Holdings closed at $25.50 per share.
-
How To Buy SBI Holdings Stock Online?
In order to purchase SBI Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 8.53% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is down 1.66% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.53% over the past day.
